BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2475 related articles for article (PubMed ID: 19351806)

  • 1. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromedin B induces angiogenesis via activation of ERK and Akt in endothelial cells.
    Park HJ; Kim SR; Bae SK; Choi YK; Bae YH; Kim EC; Kim WJ; Jang HO; Yun I; Kim YM; Bae MK
    Exp Cell Res; 2009 Nov; 315(19):3359-69. PubMed ID: 19703440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
    Mehta VB; Zhou Y; Radulescu A; Besner GE
    Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Wang Y; Wei X; Xiao X; Hui R; Card JW; Carey MA; Wang DW; Zeldin DC
    J Pharmacol Exp Ther; 2005 Aug; 314(2):522-32. PubMed ID: 15840765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor-B promotes in vivo angiogenesis.
    Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI
    Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates CD151-induced endothelial cell proliferation and cell migration.
    Zheng ZZ; Liu ZX
    Int J Biochem Cell Biol; 2007; 39(2):340-8. PubMed ID: 17045834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade.
    Chao TH; Tseng SY; Li YH; Liu PY; Cho CL; Shi GY; Wu HL; Chen JH
    Clin Sci (Lond); 2012 Aug; 123(3):147-59. PubMed ID: 22339730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
    Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
    Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of direct angiogenesis in vitro and in vivo by Puerariae flos extract via activation of MEK/ERK-, PI3K/Akt/eNOS-, and Src/FAK-dependent pathways.
    Chung BH; Cho YL; Kim JD; Jo HS; Won MH; Lee H; Ha KS; Kwon YG; Kim YM
    Phytother Res; 2010 Jun; 24(6):934-40. PubMed ID: 19960515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
    Adya R; Tan BK; Punn A; Chen J; Randeva HS
    Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
    Circ Res; ; . PubMed ID: 15044323
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 124.